Welcome to our dedicated page for CONCENTRA GROUP HOLDINGS PAREN SEC filings (Ticker: CON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Concentra Group Holdings Parent, Inc. (NYSE: CON) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a U.S. public issuer in the healthcare and occupational health services sector. Concentra files current reports on Form 8-K to communicate material events, including quarterly financial results, dividend declarations, share repurchase authorizations, and governance changes such as director appointments and executive equity awards.
Recent Form 8-K filings describe the company’s financial results for quarters ended June 30 and September 30, 2025, with accompanying press releases and presentations furnished as exhibits. These materials outline revenue performance, income from operations, patient visit metrics, and the expansion of Concentra’s network of occupational health centers and onsite health clinics. Other 8-K filings detail cash dividend declarations and the authorization of a share repurchase program, providing insight into the company’s capital allocation decisions.
Additional filings report governance-related events. For example, Concentra has filed 8-Ks regarding the appointment of new members to its Board of Directors and the grant of restricted stock to named executive officers under its equity incentive plan. These disclosures help investors understand changes in the company’s leadership and executive compensation structure. The company has also filed 8-Ks related to preliminary operational metrics and presentations at investor conferences.
Through Stock Titan, users can review these SEC filings alongside AI-powered summaries that explain key points from documents such as Form 8-K and related exhibits. Real-time updates from the EDGAR system help ensure that new filings for CON are reflected promptly, while AI-generated highlights can assist in identifying important information about financial performance, dividends, share repurchases, and governance matters without reading every line of each filing.
Concentra Group Holdings Parent, Inc. furnished an investor presentation containing preliminary, unaudited operational metrics for the quarter ended December 31, 2025. The presentation, filed as Exhibit 99.1, will be used at the J.P. Morgan Healthcare Conference at 9:00 A.M. PT on January 14 and a recording will later be posted on the company’s investor relations website. The information is being provided under Items 2.02 and 7.01 and is designated as furnished rather than filed, meaning it is not subject to certain liability provisions and is not automatically incorporated into other Securities Act or Exchange Act filings.
Concentra Group Holdings Parent, Inc. reported an insider transaction by its Chief Executive Officer and director involving a gift of common stock. On December 17, 2025, the reporting person made a gift of 89,081 shares of common stock to the Cynthia Lee Newton Beneficiary Trust, recorded at a price of $0 per share under transaction code G.
Following the transaction, the reporting person holds 393,750 shares of common stock directly. The Form 4 also shows 89,081 shares held indirectly through the Cynthia Lee Newton Beneficiary Trust. The filing explains that the reporting person is not a trustee of the trust, does not control its investments, and therefore has no reportable pecuniary interest in the shares held by the trust.
Concentra Group Holdings Parent, Inc. executive Timothy F. Ryan reported a routine share withholding related to equity compensation. On 11/26/2025, 5,903 shares of common stock were disposed of at $21.04 per share under transaction code “F,” indicating shares were withheld to cover tax obligations from the vesting of restricted stock. After this transaction, he beneficially owned 114,097 shares of common stock directly. Ryan serves as Executive Vice President & Chief Legal Counsel, and this filing reflects administrative management of taxes on equity awards rather than an open-market sale.
Concentra Group Holdings Parent, Inc.11/26/2025, an officer disposed of 3,935 shares of common stock at $21.04 per share, leaving 76,163 shares beneficially owned after the transaction. The filing classifies the transaction under code F, and the explanation states that the shares were withheld to satisfy tax obligations arising from the vesting of restricted stock. The reporting person serves as Executive Vice President and Chief Operating Officer, Onsite Health & Telemedicine, and the ownership is reported as held directly.
Concentra Group Holdings Parent, Inc. reported an insider share transaction by an executive officer. On 11/26/2025, the Executive Vice President and Chief Accounting Officer had 5,903 shares of common stock withheld at a price of $21.04 per share to cover tax obligations from the vesting of restricted stock. After this tax withholding, the officer beneficially owned 114,097 shares of common stock directly.
Concentra Group Holdings Parent, Inc. reported an insider equity transaction by an executive officer. On 11/26/2025, common stock totaling 5,903 shares was disposed of at a price of $21.04 per share. The filing explains that these shares were withheld to cover tax obligations from the vesting of restricted stock, rather than an open-market sale. After this tax withholding, the reporting person beneficially owned 114,097 shares of common stock directly.
Concentra Group Holdings Parent, Inc. reported an insider transaction by its Executive Vice President and Chief Operating Officer - East. On 11/26/2025, 6,449 shares of common stock were disposed of at a price of $21.04 per share, coded as an "F" transaction, which means the shares were withheld to cover tax obligations arising from the vesting of restricted stock rather than an open market sale. Following this tax-withholding event, the executive directly beneficially owned 113,551 shares of Concentra common stock.
Concentra Group Holdings Parent, Inc. insider reports tax-related share withholding. An executive officer reported a Form 4 transaction involving the company’s common stock on 11/26/2025. A total of 5,903 shares of common stock were disposed of in a transaction coded “F,” meaning the shares were withheld by the company to satisfy tax obligations triggered by the vesting of restricted stock, rather than sold on the open market.
After this tax-withholding event, the reporting person beneficially owns 114,097 shares of Concentra Group Holdings Parent, Inc. common stock in direct ownership form. The filer serves as Executive Vice President, Chief Reimbursement & Government Relations Officer, and filed as a single reporting person.
Concentra Group Holdings Parent, Inc. insider trading report: A company officer reported a routine share withholding related to equity compensation. On 11/26/2025, 17,708 shares of common stock were disposed of at $21.04 per share under transaction code "F," which indicates shares were withheld to cover tax obligations from the vesting of restricted stock. After this transaction, the reporting person directly beneficially owned 342,292 shares of common stock. The reporting person serves as President & Chief Financial Officer of Concentra Group Holdings Parent, Inc.
Concentra Group Holdings Parent, Inc. reported an insider transaction by its Executive Vice President, Chief Marketing and Innovation Officer. On 11/26/2025, the officer had 5,903 shares of common stock disposed of at $21.04 per share, coded as an "F" transaction, meaning the shares were withheld to cover tax obligations from the vesting of restricted stock. After this tax withholding, the officer directly beneficially owned 114,097 shares of Concentra common stock.
FAQ
What is the current stock price of CONCENTRA GROUP HOLDINGS PAREN (CON)?
What is the market cap of CONCENTRA GROUP HOLDINGS PAREN (CON)?
